ArticleTargeted oncology2026

Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer.

Jacob Sands et al.PubMed ↗Publisher ↗

No numbers read from the abstract.